Research graph
References from Microbial diversity and antimicrobial susceptibility in endotracheal tube biofilms recovered from mechanically ventilated COVID-19 patients. Local targets link to admitted publications; unresolved targets remain external evidence.
Clinical characteristics and co-infections of 354 hospitalized patients with COVID-19 in Wuhan, China: a retrospective cohort study
10.1016/j.micinf.2020.05.007 · 2020 · External reference
Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19
10.1016/s2213-2600(20)30237-x · 2020 · External reference
Organisms causing secondary pneumonias in COVID-19 patients at 5 UK ICUs as detected with the FilmArray test
2020 · External reference
Co-infection with respiratory pathogens among COVID-2019 cases
10.1016/j.virusres.2020.198005 · 2020 · External reference
Secondary infection in COVID-19 critically ill patients: a retrospective single-center evaluation
10.1186/s12879-022-07192-x · 2022 · External reference
Low rate of bacterial co-infection in patients with COVID-19
10.1016/s2666-5247(20)30036-7 · 2020 · External reference
Covid-19 in critically ill patients in the seattle region - case series
10.1056/nejmoa2004500 · 2020 · External reference
COVID-19 autopsies reveal underreporting of SARS-CoV-2 infection and scarcity of Co-infections
10.3389/fmed.2022.868954 · 2022 · External reference
Bacterial co-infection at hospital admission in patients with COVID-19
10.1016/j.ijid.2022.03.003 · 2022 · External reference
Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis
10.1016/j.cmi.2020.07.016 · 2020 · External reference
Co-infections in people with COVID-19: a systematic review and meta-analysis
10.1016/j.jinf.2020.05.046 · 2020 · External reference
Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study
10.1016/s2666-5247(21)00090-2 · 2021 · External reference
Hospital-acquired infections in critically ill patients with COVID-19
10.1016/j.chest.2021.04.002 · 2021 · External reference
Community-acquired and hospital-acquired respiratory tract infection and bloodstream infection in patients hospitalized with COVID-19 pneumonia
10.1186/s40560-021-00526-y · 2021 · External reference
SARS-CoV-2, bacterial co-infections, and AMR: the deadly trio in COVID-19?
10.15252/emmm.202012560 · 2020 · External reference
Viral and bacterial interactions in the upper respiratory tract
10.1371/journal.ppat.1003057 · 2013 · External reference
Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States
10.1097/ccm.0b013e3182416f23 · 2012 · External reference
The role of pneumonia and secondary bacterial infection in fatal and serious outcomes of pandemic influenza a(H1N1)pdm09
10.1186/s12879-018-3548-0 · 2018 · External reference
Microbial signatures in the lower airways of mechanically ventilated COVID-19 patients associated with poor clinical outcome
10.1038/s41564-021-00961-5 · 2021 · External reference
Tracheal tube biofilm as a source of bacterial colonization of the lung
10.1128/jcm.27.9.2014-2018.1989 · 1989 · External reference
Endotracheal tube: friend or foe? Bacteria, the endotracheal tube, and the impact of colonization and infection
10.1053/j.semperi.2012.06.008 · 2012 · External reference
Endotracheal tube biofilm inoculation of oral flora and subsequent colonization of opportunistic pathogens
10.1016/j.ijmm.2010.02.005 · 2010 · External reference
Description and microbiology of endotracheal tube biofilm in mechanically ventilated subjects
10.4187/respcare.02722 · 2015 · External reference
Molecular mechanisms of antimicrobial tolerance and resistance in bacterial and fungal biofilms
10.1016/j.tim.2014.02.001 · 2014 · External reference
Antimicrobial tolerance and metabolic adaptations in microbial biofilms
10.1016/j.tim.2019.05.003 · 2019 · External reference
Implications of endotracheal tube biofilm for ventilator-associated pneumonia
10.1007/s001340051014 · 1999 · External reference
The presence of antibiotic-resistant nosocomial pathogens in endotracheal tube biofilms and corresponding surveillance cultures
10.1111/2049-632x.12100 · 2013 · External reference
Technologic advances in endotracheal tubes for prevention of ventilator-associated pneumonia
10.1378/chest.11-2420 · 2012 · External reference
Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: the NASCENT randomized trial
10.1001/jama.300.7.805 · 2008 · External reference
Activity of a silver-coated endotracheal tube in preclinical models of ventilator-associated pneumonia and a study after extubation
10.1097/ccm.0b013e3181cd12b8 · 2010 · External reference
Biofilm formation on three different endotracheal tubes: a prospective clinical trial
10.1186/s13054-020-03092-1 · 2020 · External reference
Airway devices in ventilator-associated pneumonia pathogenesis and prevention
10.1016/j.ccm.2018.08.001 · 2018 · External reference
Developing selective media for quantification of multispecies biofilms following antibiotic treatment
10.1371/journal.pone.0187540 · 2017 · External reference
Selective medium for Branhamella catarrhalis with acetazolamide as a specific inhibitor of Neisseria spp
10.1128/jcm.26.12.2544-2548.1988 · 1988 · External reference
A new selective differential medium for isolation of Stenotrophomonas maltophilia
10.1007/bf01709373 · 1996 · External reference
Rapid lysostaphin test to differentiate Staphylococcus and Micrococcus species
10.1128/jcm.23.6.1044-1045.1986 · 1986 · External reference
Biochemical tests for the identification of aerobic bacteria
2016 · External reference
Introducing SPeDE: high-throughput dereplication and accurate determination of microbial diversity from matrix-assisted laser desorption-ionization time of flight mass spectrometry data
10.1128/msystems.00437-19 · 2019 · External reference
Human and extracellular DNA depletion for metagenomic analysis of complex clinical infection samples yields optimized viable microbiome profiles
10.1016/j.celrep.2019.01.091 · 2019 · External reference
Unresolved reference
2019 · External reference
Unresolved reference
2013 · External reference
DADA2: high-resolution sample inference from Illumina amplicon data
10.1038/nmeth.3869 · 2016 · External reference
Cutadapt removes adapter sequences from high-throughput sequencing reads
2011 · External reference
The SILVA ribosomal RNA gene database project: improved data processing and web-based tools
2013 · External reference
The UNITE database for molecular identification of fungi: handling dark taxa and parallel taxonomic classifications
10.1093/nar/gky1022 · 2019 · External reference
phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data
10.1371/journal.pone.0061217 · 2013 · External reference
EUCAST disk diffusion method for antimicrobial susceptibility testing
2020 · External reference
Unresolved reference
2018 · External reference
Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by broth dilution
10.1046/j.1469-0691.2003.00790.x · 2003 · External reference
Breakpoint tables for interpretation of MICs and zone diameters
2020 · External reference
Breakpoint tables for interpretation of MICs for antifungal agents, version 10.0
2020 · External reference
Unresolved reference
2020 · External reference
Bacteremia caused by Slackia exigua: a report of two cases and literature review
10.1016/j.jiac.2019.06.006 · 2020 · External reference
Citrobacter infections in a general hospital: characteristics and outcomes
10.1007/s10096-008-0598-z · 2009 · External reference
Morganella morganii, a non-negligent opportunistic pathogen
10.1016/j.ijid.2016.07.006 · 2016 · External reference
Multidrug-resistant Enterobacter cloacae complex emerging as a global, diversifying threat
10.3389/fmicb.2019.00044 · 2019 · External reference
The significance of Candida in the human respiratory tract: our evolving understanding
2017 · External reference
The endotracheal tube microbiome associated with Pseudomonas aeruginosa or Staphylococcus epidermidis
10.1038/srep36507 · 2016 · External reference
The microbiome of the lung
10.1016/j.trsl.2012.02.005 · 2012 · External reference
The lung microbiome in health and disease
10.7861/clinmedicine.17-6-525 · 2017 · External reference
The lung microbiome, immunity, and the pathogenesis of chronic lung disease
10.4049/jimmunol.1600279 · 2016 · External reference
Bronchial microbiome of severe COPD patients colonised by Pseudomonas aeruginosa
10.1007/s10096-013-2044-0 · 2014 · External reference
The microbiome in mechanically ventilated patients
10.1097/qco.0000000000000352 · 2017 · External reference
The co-pathogenesis of influenza viruses with bacteria in the lung
10.1038/nrmicro3231 · 2014 · External reference
Risk factors for nosocomial infection among hospitalised severe influenza A(H1N1)pdm09 patients
10.1016/j.rmed.2017.11.017 · 2018 · External reference
Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States
2009 · External reference
Clinical findings in 111 cases of influenza A (H7N9) virus infection
10.1056/nejmoa1305584 · 2013 · External reference
Bacterial co-infections with SARS-CoV-2
10.1002/iub.2356 · 2020 · External reference
Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?
10.1086/338782 · 2002 · External reference
Antibiotic resistance in Pseudomonas aeruginosa - mechanisms, epidemiology and evolution
10.1016/j.drup.2019.07.002 · 2019 · External reference
Increasing prevalence of antimicrobial resistance in intensive care units
10.1097/00003246-200104001-00002 · 2001 · External reference
Genomic variation among contemporary Pseudomonas aeruginosa isolates from chronically infected cystic fibrosis patients
10.1128/jb.01050-12 · 2012 · External reference
